About the group
The Cancer Mechanisms and Biomarkers Research Group (formally known as the Cancer Research Group) within the Centre for Optimal Health is based in the University of Westminster's School of Life Sciences. The research group focuses on detection, prevention, molecular mechanisms, and investigation of new biomarkers for cancer. Studies are undertaken at the genetic and epigenetic, transcriptomic and proteomic levels. Molecular modeling of protein ligand interactions are performed in collaboration with the Centre for Parallel Computing. Novel platforms for studying tumour characteristics and responsiveness to treatment are available in the group.
Projects and initiatives
Find out about the funded projects undertaken by the Cancer Mechanisms and Biomarkers research group.
People
Publications
Cancer Mechanisms and Biomarkers recent publications include:
- Dirimtekin E, Mortoglou M, Alavanda C, Benomar Yemlahi A, Arslan Ates E, Guney I and Uysal-Onganer P. (2023). miR-34a-FOXP1 loop in Ovarian Cancer. ACS Omega, Jul 18;8(30):27743-27750. doi: 10.1021/acsomega.3c03867.eCollection 2023 Aug 1.
- Koushyar S, Uysal-Onganer P, Jiang W and Dart DA. (2023). Prohibitin links cell cycle, motility and invasion in Prostate Cancer cells. J. Mol. Sci. 2023 Jun 8;24(12):9919. doi: 10.3390/ijms24129919